Aromatic compound-dependent (aro) derivatives of three mouse-virulent strains of SalmoneUa choleraesuis (Salmonella cholerae-suis) were constructed and shown to be nonvirulent for mice (intraperitoneal [i.p.] 50% lethal dose [LDo], >5 x 106 CFU). A pur derivative and a thy derivative, each of a different virulent parent, remained moderately virulent (i.p. LD50s for BALB/c mice, ca. 105 and 5 x 104 CFU, respectively). Tested as live vaccines i.p., the aro strains were ineffective in salmonella-susceptible BALB/c and C57BL/6 mice but were somewhat effective in salmonella-resistant CBA/J mice and in outbred CD-1 mice. The pur and thy strains were effective as live vaccines in BALB/c mice when given in sublethal doses. Two previously isolated nonvirulent galE derivatives of S. choleraesuis (i.p. LDSO in BALB/c mice, >106 CFU) were also ineffective as live vaccines in BALB/c and C57BL/6 mice. The main antigenic difference between S. choleraesuis (0-6,7) and S. typhimurium (0) (1) (2) (3) (4) 12 ) is in 0-antigen character, thought to largely determine the specificity of protection in salmonellosis. Paired, nearly isogenic 0-6,7 and 0-4,12 derivatives were constructed from an aro S. typhimurium strain of proven efficacy as a live vaccine. Used as live vaccines, the 0-4,12 member protected BALB/c mice against challenge with virulent S. typhimurium, whereas the 0-6,7 member did not protect against virulent S. choleraesuis. However, BALB/c mice vaccinated with the 0-6,7 member and mice vaccinated with an aro S. choleraesuis strain were protected against challenge with a moderately virulent (LD50, 5 x 104 CFU) 0-6,7 derivative of an S. typhimurium strain.
Salmonella choleraesuis (Salmonella cholerae-suis) is the cause of swine paratyphoid, a widespread diesease of pigs (2, 3, 11, 16, 32) . Human infections with this organism are clinically distinctive, with a high incidence of septicemia and multiple focal abscesses but a low rate of intestinal involvement and a case fatality rate of 16 to 20% (19, 27, 38) .
No vaccine is known to be effective in the control of S. choleraesuis infections. A rough variant of S. choleraesuis isolated by H. W. Smith (30) has been used as a live vaccine in Europe but is not in use in the United States. Live attenuated strains of salmonella (5, 8, 12, 13, 24, (33) (34) (35) and killed organisms given with complete Freund adjuvant (5, 33, 35) are generally effective as vaccines. In some systems, even repeated administration of killed organisms without adjuvants does not protect effectively (5) . Salmonella strains of proven efficacy as live vaccines include those deficient in aromatic biosynthesis (aro mutants) and those deficient in the enzyme UDP-glucose-4-epimerase (galE mutants). Aromatic compound-deficient mutants of S. typhimurium and of S. dublin constructed by S. K. Hoiseth and B. A. D. Stocker were highly effective as live vaccines in both mice and calves (13, 24, 29) . galE mutants of Salmonella typhimurium were also effective as live vaccines in mice (8) and calves (39) . A galE mutant of Salmonella typhi designated Ty2la (9) is currently undergoing trials in humans and has proven effective as a live vaccine against typhoid.
This study was intended: (i) to test the effects on the virulence of S. choleraesuis of auxotrophic mutations that reduce the virulence of other salmonella species; (ii) to evaluate nonvirulent auxotrophic strains and also two previously isolated galE mutants (21) for efficacy as live vaccines in mice. The auxotrophic derivatives tested comprised those requiring aromatic compounds (aro), purine (pur), and thymine (thy).
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MATERIALS AND METHODS
Media. The complete media used were Oxoid blood agar base (code CM55; Oxoid Ltd., London, England), Oxoid nutrient broth (code CM67), Difco MacConkey agar (Difco Laboratories, Detroit, Mich.), and Difco MacConkey agar base supplemented with the desired carbohydrate source (5 g/liter). The defined medium used was that of Davis and Mingioli (4) , with glycerol (5 ml/liter) and sodium citrate (0.5 g/liter) as carbon sources. In some experiments, these carbon sources were replaced by galactose (5 g/liter) to make o-galactose agar.
Phages and genetic methods. A high-transducing derivative of bacteriophage P22, P22 HT105/1 int (28), was used for transductions between strains of S. typhimurium. No known transducing phages adsorb to smooth strains of S. typhimurium (O group B) and S. choleraesuis (O group C1). Rough derivatives of S. typhimurium of the types rfaG, rfaH, galU, and galE, however, adsorb phage P1 (6, 22) , and preliminary tests showed, as expected, that galE mutants of S. choleraesuis also adsorb the phage. Transductions Construction of aro and aro+ S. typhimurium strains with 0 antigen 6,7. The rib region of the salmonella chromosome determines 0-antigen structure. We replaced the group B-rib region of SL5225 (UCD108-11 galE aroA hisC) with that of S. CHOLERAESUIS MUTANTS AS LIVE VACCINES 957 0-6,7 but not in 0-4,12 antiserum. A his+ Cl-rfb+ transductant of SL5225 was subsequently made smooth by transduction to gal+ by using a Pl::Tn9 c(ts) lysate of an rfaH strain of S. typhimurium. One clone determined by phage pattern, galactose fermentation, and nutritional tests to be a his+ Cl-rfb+ gal+ derivative of SL5225 was numbered SL2856. Its UCD108-11 ancestry was confirmed by its lysogeny for an 01-converting phage, antibiogram, and plasmid profile. SL2856 should be like a typical aroA derivative of S. typhimurium UCD108-11 in phenotype except for lipopolysaccharide character, for which it should resemble S. choleraesuis. Compared with S. choleraesuis, however, SL2856 was shown to synthesize very little enterobacterial common antigen (ECA), a bacterial surface component and virulence factor for salmonella (36) ; this was determined by indirect hemagglutination (20) . Almost complete absence of ECA in such hybrids is expected because in S. choleraesuis the rfe locus alone, at minute 84, suffices for synthesis of normal levels of ECA, whereas in S. typhimurium, both rib and rfe functions are required so that a combination of B-rfe and C-rib loci, as in SL2856, results in the synthesis of minimal amounts of ECA (20) . When used as a live vaccine, however, such a strain should elicit protection specific for S. choleraesuis since the specificity of protection in salmonellosis is determined in a large part by the 0 antigen (18) .
SL4381 is an aro+ but 0-6,7 derivative of UCD108-11. For construction of this strain, SL2856 (UCD108-11 aroA) was crossed with Salmonella abony SH566 strA HfrH3. Tetracycline-resistant (25 jig/ml) aro+ recombinants of SL2856 were selected on minimal agar. A clone identified as an aro+ derivative of SL2856 was numbered SL4381. The intraperitoneal (i.p.) 50% lethal dose (LD50) of SL4381 for BALB/c mice was determined to be 4 x 104 CFU. Its relatively low virulence compared with its UCD108-11 ancestor (LD50, <5 CFU) presumably results in part from change in 0 antigen from 4,12 to 6,7 (37) and in part from its inability to make normal levels of ECA (36) .
Animal studies. Specific-pathogen-free BALB/c mice were from the Department of Radiology, Stanford University, Stanford, Calif.; CD-1 mice were from Charles River Breeding Laboratories, Inc., Wilmington, Mass.; CBA/J mice were from Jackson Laboratory, Bar Harbor, Maine; and C57BL/6 mice were from The Institute for Medical Research, San Jose, Calif. Bacteria were grown overnight in nutrient broth at 37°C without shaking. Mice were inoculated i.p. with 0.1 ml of appropriate dilutions in normal saline. For LD50 determinations (23), animals were generally observed for 30 days, and mice used for protection determination were observed for at least 45 days. All dead animals were autopsied for gross pathology, especially of the liver. Cultures of livers and spleens were also done for bacteria. LD50s of SL4381 given 42 days after vaccination (Table 6 , experiment 14). Thus, challenge with an 0-6,7 derivative of S. typhimurium revealed fairly good protection by either one or two doses of aro 0-6,7 bacteria, either S. choleraesuis or S. typhimurium made 0-6,7.
Protection of BALB/c mice by i.p. vaccination with thy and pur derivatives of S. chokraesuis. As noted previously, the Table 2 ). This is the result expected if aromatic compound-dependent strains are nonvirulent because of nonavailability in host tissues of p-aminobenzoic acid, which is essential to such mutants.
The one purine-dependent mutant and the one thyminedependent mutant of S. choleraesuis studied were of reduced virulence, with i.p. LD50s in Ity' mice ca. 500 times greater than those of their parent strains ( Table 2 ). The purHD343 deletion mutation introduced into S. choleraesuis has removed parts of two genes in the purJHD operon (10) , needed for two steps in the de novo pathway leading to IMP; the mutation must therefore have caused a complete block in this pathway. Several workers have reported reduced virulence as a consequence of purine auxotrophy (1, 7, 14) . The degree of loss of virulence associated with requirement for purine appears to depend on both the gene affected and the bacterial species. Mutants of Bacillus anthracis (14) and of S. dublin (W. McFarland and B. A. D. Stocker, unpublished data) unable to convert IMP to AMP are nonvirulent; by contrast, those responding to hypoxanthine (i.e., with a block in any of the reactions leading to IMP) or with a requirement for guanine (i.e., with a block between IMP and GMP) retained virulence, either partial (McFarland and Stocker, unpublished data) or complete (14) . The hypoxanthine-responding pur derivative of S. choleraesuis, which we constructed and found to be of reduced virulence, thus behaved like hypoxanthine-responding pur derivatives of S. dublin. Thymine-requiring mutants of several salmonella species are of reduced virulence for chicks (31) , and thymine-requiring mutants of S. typhimurium are of reduced virulence for mice (C. Spurdon and B. A. D. Stocker, unpublished data). The thymine-requiring mutant of S. choleraesuis we studied was likewise of moderately reduced virulence.
Of the several classes of auxotrophic strains studied, only the aroA were sufficiently nonvirulent to be of interest for possible use as live vaccines. However, aro derivatives of the three S. choleraesuis strains were not effective as live vaccines when given i.p. in one to three doses to BALB/c and C57BL/6 mice. Such mice died from modest challenge doses of virulent S. choleraesuis strains, even after two vaccinations. The only aro strain, SL2822, tested in three doses gave virtually no protection to C57BL/6 mice and only partial protection to BALB/c mice challenged with 600 or 6,000 LD50s of its virulent parent. These results differ from the excellent protection given by aro and galE live vaccines of S. typhimurium and S. dublin, even in salmonellasusceptible mice. They suggest two possibilities. (i) aro S. choleraesuis, either because of its 0 antigen character or from some other cause, when given as live vaccine to mice does not elicit as strong an immune response as do similarly given aro mutants of S. typhimurium [O-(1),4,(5),12] and S. dublin (0-9,12); or (ii) S. choleraesuis wild-type strains (for unknown reasons) can multiply to cause death, even in mice which have mounted a strong immune response, whereas S. typhimurium and S. dublin wild type cannot.
To investigate these possibilities, we constructed and used as a live vaccine an aroA strain of S. typhimurium UCD108-11 given the 0-6,7 antigen of S. choleraesuis 381.
The aim was to place the 0 antigen (believed to be the main protective immunogen in salmonella species) of S. choleraesuis in a proven effective live-vaccine strain. The resulting aro hybrid strain, SL2856, proved as ineffective as SL2822 (S. choleraesuis 38, aroA) in protecting BALB/c mice against challenge with strain 38, (Table 6) . By contrast, a single dose of SL2888, the 0-1,4,12 nearly isogenic sister of SL2856, effectively protected the same mouse strain against challenge with its virulent parent, UCD108-11. This result is compatible with the first hypothesis, that S. choleraesuis fails to elicit an adequate immune response, if this failure is a necessary consequence of its 0-6,7 antigen character-but is also compatible with the second hypothesis, that virulent S. choleraesuis but not virulent S. typhimurium can cause fatal infections even in mice that have mounted a strong immune response.
Unlike the 0-6,7 aro strains, the pur (SL2880) and the thy (SL2815) derivatives of S. choleraesuis effectively protected BALB/c mice against challenge with their parental strains INFECT. IMMUN.
on August 27, 2017 by guest http://iai.asm.org/ Downloaded from when used as live vaccine in sublethal doses. This demonstrates that sublethal infection with moderately virulent derivatives of S. choleraesuis (by implication also sublethal infection by fully virulent strains) can immunize mice effectively. Mice that survived sublethal inocula of the thy or pur strains suffered prolonged illness (ruffled fur, overt illness, or both for 2 to 3 weeks), indicating that the strains multiplied and persisted in vivo. In studies to be separately published we have shown that pur and thy S. choleraesuis given i.p. to mice multiplied greatly and persisted in their livers and spleens and that aro 0-4,12 S. typhimurium multiplied only slightly but persisted, whereas aro S. choleraesuis or aro 0-6,7 S. typhimurium organisms were rapidly killed after i.p. injection. We interpret these data to mean that elicitation of protective immunity against S. choleraesuis in Itys mice requires a degree of antigenic stimulation difficult to achieve with nonvirulent bacteria of this species because of rapid elimination of the bacteria from the reticuloendothelial system.
BALB/c mice vaccinated once or twice either with an aro strain of S. choleraesuis (SL2822) or with a hybrid aro strain, S. typhimurium UCD108-11 aro made 0-6,7 (SL2856), were well protected against challenge with 200 LD50s of SL4381 (S. typhimurium UCD108-11 aro+ made 0-6,7) ( Table 6 , experiments 13 and 14) . Similar vaccination very poorly protected against S. choleraesuis 38, challenge (Table 6 , experiment 12). This shows that vaccination of Itys mice with live aro 0-6,7 bacteria does elicit some degree of protective immunity in Ity5 mice and so supports the hypothesis that S. choleraesuis can multiply in Ity' mice even if they have developed a strong immune response to live vaccine administration.
A different picture was seen in experiments with inbred Ityr CBA/J mice (Table 4) . A single dose of SL2822 (S. choleraesuis aro) gave better protection in CBA/J mice than did two doses in Itys mice. Our data, like those of Robson and Vas (25) , show that Ityr mice are more readily immunized against salmonellosis than are Itys mice. CD-1 (outbred) mice also were better protected against S. choleraesuis by vaccination with SL2822 (aro S. choleraesuis) than were Itys (BALB/c and C57BL/6) mice. Their susceptibility to infection with strain 38, and the level of protective effects observed after vaccination with SL2822, however, varied between two experiments.
S. choleraesuis is a highly lethal serotype that is associated with higher case fatality rates in humans than are other salmonellae, and the infection caused in humans is mainly septicemia, with organisms being rarely isolated from the intestinal tract. Our results provide additional evidence that S. choleraesuis differs from other pathogenic salmonella species in several other ways. Some galE mutants of the organism retain high virulence, unlike those of S. typhimurium and S. typhi. The aro derivatives of S. choleraesuis strains were nonvirulent as expected but unexpectedly were not effective as live vaccines when given i.p. to Itys mice.
Moreover, mice vaccinated with SL2822 (38, aroA), though not protected against challenge with strain 381, were well protected against challenge with a strain of S. typhimurium whose 0-1,4,12 antigen had been replaced with that (0-6,7) of strain 381. These results suggest an unusual mode of interaction with the defense system of the host. Our data suggest two possibilities that together explain the nonprotection by vaccination with nonvirulent derivatives of S.
choleraesuis. The first is that live bacteria with 0 antigen 6,7 are poorly immunogenic in mice, perhaps because of poor persistence. The second is that virulent S. choleraesuis strains can multiply to kill mice even though the mice have mounted a strong immunologic response.
